150 related articles for article (PubMed ID: 22698798)
21. Receptor for Advanced Glycation End Products (RAGE) Serves a Protective Role during Klebsiella pneumoniae - Induced Pneumonia.
Achouiti A; de Vos AF; van 't Veer C; Florquin S; Tanck MW; Nawroth PP; Bierhaus A; van der Poll T; van Zoelen MA
PLoS One; 2016; 11(1):e0141000. PubMed ID: 26824892
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection.
Drennan MB; Nicolle D; Quesniaux VJ; Jacobs M; Allie N; Mpagi J; Frémond C; Wagner H; Kirschning C; Ryffel B
Am J Pathol; 2004 Jan; 164(1):49-57. PubMed ID: 14695318
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-155 knockout mice are susceptible to Mycobacterium tuberculosis infection.
Iwai H; Funatogawa K; Matsumura K; Kato-Miyazawa M; Kirikae F; Kiga K; Sasakawa C; Miyoshi-Akiyama T; Kirikae T
Tuberculosis (Edinb); 2015 May; 95(3):246-50. PubMed ID: 25846955
[TBL] [Abstract][Full Text] [Related]
24. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice.
Wakeham J; Wang J; Magram J; Croitoru K; Harkness R; Dunn P; Zganiacz A; Xing Z
J Immunol; 1998 Jun; 160(12):6101-11. PubMed ID: 9637527
[TBL] [Abstract][Full Text] [Related]
25. DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infection.
Hessmann M; Rausch A; Rückerl D; Adams PS; Simon M; Gilfillan S; Colonna M; Ehlers S; Hölscher C
Immunobiology; 2011 May; 216(5):639-47. PubMed ID: 21122940
[TBL] [Abstract][Full Text] [Related]
26. A new model for chronic and reactivation tuberculosis: Infection with genetically attenuated Mycobacterium tuberculosis in mice with polar susceptibility.
Kondratieva TK; Kapina MA; Rubakova EI; Kondratieva EV; Nikonenko BV; Majorov KB; Dyatlov AV; Linge IA; Apt AS
Tuberculosis (Edinb); 2018 Dec; 113():130-138. PubMed ID: 30514495
[TBL] [Abstract][Full Text] [Related]
27. The role of the receptor for advanced glycation end-products in a murine model of silicosis.
Ramsgaard L; Englert JM; Tobolewski J; Tomai L; Fattman CL; Leme AS; Kaynar AM; Shapiro SD; Enghild JJ; Oury TD
PLoS One; 2010 Mar; 5(3):e9604. PubMed ID: 20333255
[TBL] [Abstract][Full Text] [Related]
28. Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia.
van Zoelen MA; van der Sluijs KF; Achouiti A; Florquin S; Braun-Pater JM; Yang H; Nawroth PP; Tracey KJ; Bierhaus A; van der Poll T
Virology; 2009 Sep; 391(2):265-73. PubMed ID: 19592063
[TBL] [Abstract][Full Text] [Related]
29. Emphysema requires the receptor for advanced glycation end-products triggering on structural cells.
Waseda K; Miyahara N; Taniguchi A; Kurimoto E; Ikeda G; Koga H; Fujii U; Yamamoto Y; Gelfand EW; Yamamoto H; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2015 Apr; 52(4):482-91. PubMed ID: 25188021
[TBL] [Abstract][Full Text] [Related]
30. Persistent infection with virulent but not avirulent Mycobacterium tuberculosis in the lungs of mice causes progressive pathology.
Dunn PL; North RJ
J Med Microbiol; 1996 Aug; 45(2):103-9. PubMed ID: 8683545
[TBL] [Abstract][Full Text] [Related]
31. Conditional overexpression of receptors for advanced glycation end-products in the adult murine lung causes airspace enlargement and induces inflammation.
Stogsdill MP; Stogsdill JA; Bodine BG; Fredrickson AC; Sefcik TL; Wood TT; Kasteler SD; Reynolds PR
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):128-34. PubMed ID: 23526218
[TBL] [Abstract][Full Text] [Related]
32. Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice.
Ramsgaard L; Englert JM; Manni ML; Milutinovic PS; Gefter J; Tobolewski J; Crum L; Coudriet GM; Piganelli J; Zamora R; Vodovotz Y; Enghild JJ; Oury TD
PLoS One; 2011; 6(5):e20132. PubMed ID: 21629785
[TBL] [Abstract][Full Text] [Related]
33. The receptor for advanced glycation end products promotes bacterial growth at distant body sites in Staphylococcus aureus skin infection.
Achouiti A; Van't Veer C; de Vos AF; van der Poll T
Microbes Infect; 2015 Sep; 17(9):622-7. PubMed ID: 26086798
[TBL] [Abstract][Full Text] [Related]
34. Improvement of the resistance against early Mycobacterium tuberculosis-infection in the absence of PI3Kγ enzyme is associated with increase of CD4+IL-17+ cells and neutrophils.
Cavalcanti-Neto MP; Prado RQ; Piñeros AR; Sérgio CA; Bertolini TB; Gembre AF; Ramos SG; Bonato VL
Tuberculosis (Edinb); 2018 Dec; 113():1-9. PubMed ID: 30514491
[TBL] [Abstract][Full Text] [Related]
35. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis.
Maglione PJ; Xu J; Chan J
J Immunol; 2007 Jun; 178(11):7222-34. PubMed ID: 17513771
[TBL] [Abstract][Full Text] [Related]
36. MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression.
Scanga CA; Bafica A; Feng CG; Cheever AW; Hieny S; Sher A
Infect Immun; 2004 Apr; 72(4):2400-4. PubMed ID: 15039368
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of receptors for advanced glycation end-products by alveolar epithelium influences cytodifferentiation and causes severe lung hypoplasia.
Reynolds PR; Stogsdill JA; Stogsdill MP; Heimann NB
Am J Respir Cell Mol Biol; 2011 Dec; 45(6):1195-202. PubMed ID: 21685154
[TBL] [Abstract][Full Text] [Related]
38. ST2 deficient mice display a normal host defense against pulmonary infection with Mycobacterium tuberculosis.
Wieland CW; van der Windt GJ; Florquin S; McKenzie AN; van der Poll T
Microbes Infect; 2009 Apr; 11(4):524-30. PubMed ID: 19286469
[TBL] [Abstract][Full Text] [Related]
39. Limited role of the receptor for advanced glycation end products during Streptococcus pneumoniae bacteremia.
Achouiti A; de Vos AF; de Beer R; Florquin S; van 't Veer C; van der Poll T
J Innate Immun; 2013; 5(6):603-12. PubMed ID: 23774862
[TBL] [Abstract][Full Text] [Related]
40. Histamine plays an essential regulatory role in lung inflammation and protective immunity in the acute phase of Mycobacterium tuberculosis infection.
Carlos D; Fremond C; Samarina A; Vasseur V; Maillet I; Ramos SG; Erard F; Quesniaux V; Ohtsu H; Silva CL; Faccioli LH; Ryffel B
Infect Immun; 2009 Dec; 77(12):5359-68. PubMed ID: 19822651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
